Patents by Inventor Marc Purcell

Marc Purcell has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10967021
    Abstract: The present invention provides a new use or method of use of a thylakoid extract, for oral route of administration, and a composition comprising the thylakoid extract in adjunction with an acceptable carrier for oral administration. Besides the pharmaceutical use, the thylakoid extract enters the composition of food or food supplements, or medication for its innocuity and its capacity to provide a diet enriched in anti-oxidants and anti-inflammatory compounds. Therefore, in accordance with the present invention is provided the use of athylakoid extract in the making of an oral composition for treating preventing a disease or disorder involving the formation of reactive oxygen species or inflammation. Also is provided a method for treating or preventing a disease or disorder involving the formation of reactive oxygen species inflammation in an individual, which comprises the step of orality administering an effective dose of a thylakoid extact.
    Type: Grant
    Filed: October 12, 2018
    Date of Patent: April 6, 2021
    Assignee: GROUPE SANTÉ DEVONIAN
    Inventors: Marc Purcell, Réjean Drouin
  • Patent number: 10925899
    Abstract: The present invention relates to a composition for the synthesis of ATP as an energy supplementation. The composition comprises a plant extract or a plant fraction suitable to produce ATP upon exposure to light. The present invention also relates to the isolation of such plant extract and to its use in energy drinks.
    Type: Grant
    Filed: December 22, 2016
    Date of Patent: February 23, 2021
    Inventors: Marc Purcell, Nathalie Miller
  • Publication number: 20190240276
    Abstract: The present invention provides a new use or method of use of a thylakoid extract, for oral route of administration, and a composition comprising the thylakoid extract in adjunction with an acceptable carrier for oral administration. Besides the pharmaceutical use, the thylakoid extract enters the composition of food or food supplements, or medication for its innocuity and its capacity to provide a diet enriched in anti-oxidants and anti-inflammatory compounds. Therefore, in accordance with the present invention is provided the use of athylakoid extract in the making of an oral composition for treating preventing a disease or disorder involving the formation of reactive oxygen species or inflammation . Also is provided a method for treating or preventing a disease or disorder involving the formation of reactive oxygen species inflammation in an individual, which comprises the step of orality administering an effective dose of a thylakoid extact.
    Type: Application
    Filed: October 12, 2018
    Publication date: August 8, 2019
    Inventors: Marc PURCELL, Réjean DROUIN
  • Publication number: 20190022140
    Abstract: The present invention relates to a composition for the synthesis of ATP as an energy supplementation. The composition comprises a plant extract or a plant fraction suitable to produce ATP upon exposure to light. The present invention also relates to the isolation of such plant extract and to its use in energy drinks.
    Type: Application
    Filed: December 22, 2016
    Publication date: January 24, 2019
    Inventors: Marc PURCELL, Nathalie MILLER
  • Publication number: 20190015324
    Abstract: The present document describes a buccal delivery dosage form for administration of an active ingredient, including pharmaceutically, pharmacologically, or biologically active ingredients, in the mouth of a subject. The buccal delivery dosage form by-passes the gastrointestinal tract metabolism. The buccal delivery dosage form may comprise chemical permeation enhancers, excipients, texture modulators, and active ingredients.
    Type: Application
    Filed: September 18, 2018
    Publication date: January 17, 2019
    Applicant: Technologies Khloros Inc.
    Inventor: Marc PURCELL
  • Patent number: 10124029
    Abstract: A new use or method of use of a thylakoid extract, for oral route of administration, and a composition comprising the thylakoid extract in adjunction with an acceptable carrier for oral administration. Also described is a method for treating or preventing a disease or disorder involving the formation of reactive oxygen species inflammation in an individual, which comprises the step of orally administering an effective dose of a thylakoid extract. Also described is an oral composition comprising purified thylakoids and a carrier for oral ingestion or oral administration, with the proviso that the carrier does not essentially consist of water, physiological saline or propylene glycol. The thylakoid extract or composition is also provided as a food or a food supplement or as a pellet, or encapsulated granules or powder.
    Type: Grant
    Filed: November 3, 2016
    Date of Patent: November 13, 2018
    Assignee: GROUPE SANTÉ DEVONIAN
    Inventors: Marc Purcell, Rejean Drouin
  • Patent number: 10111831
    Abstract: The present document describes a buccal delivery dosage form for administration of an active ingredient, including pharmaceutically, pharmacologically, or biologically active ingredients, in the mouth of a subject. The buccal delivery dosage form by-passes the gastrointestinal tract metabolism. The buccal delivery dosage form may comprise chemical permeation enhancers, excipients, texture modulators, and active ingredients.
    Type: Grant
    Filed: February 28, 2012
    Date of Patent: October 30, 2018
    Assignee: TECHNOLOGIES KHLOROS INC.
    Inventor: Marc Purcell
  • Patent number: 10111903
    Abstract: The present invention relates to a buccal delivery dosage form and its use for administration of a therapeutic gas for buccal mucosal absorption of the therapeutic gas in the mouth of a subject. The buccal delivery dosage form comprises at least one crystallized excipient and at least one therapeutic gas entrapped within the crystallized excipient.
    Type: Grant
    Filed: September 20, 2017
    Date of Patent: October 30, 2018
    Assignee: TECHNOLOGIES KHLÔROS INC.
    Inventor: Marc Purcell
  • Publication number: 20180008631
    Abstract: The present invention relates to a buccal delivery dosage form and its use for administration of a therapeutic gas for buccal mucosal absorption of the therapeutic gas in the mouth of a subject. The buccal delivery dosage form comprises at least one crystallized excipient and at least one therapeutic gas entrapped within the crystallized excipient.
    Type: Application
    Filed: September 20, 2017
    Publication date: January 11, 2018
    Inventor: Marc PURCELL
  • Publication number: 20170239290
    Abstract: The present invention relates to a buccal delivery dosage form and its use for administration of a therapeutic gas for buccal mucosal absorption of the therapeutic gas in the mouth of a subject. The buccal delivery dosage form comprises at least one crystallized excipient and at least one therapeutic gas entrapped within the crystalized excipient.
    Type: Application
    Filed: August 19, 2015
    Publication date: August 24, 2017
    Inventor: Marc PURCELL
  • Publication number: 20170049831
    Abstract: A new use or method of use of a thylakoid extract, for oral route of administration, and a composition comprising the thylakoid extract in adjunction with an acceptable carrier for oral administration. Also described is a method for treating or preventing a disease or disorder involving the formation of reactive oxygen species inflammation in an individual, which comprises the step of orally administering an effective dose of a thylakoid extract. Also described is an oral composition comprising purified thylakoids and a carrier for oral ingestion or oral administration, with the proviso that the carrier does not essentially consist of water, physiological saline or propylene glycol. The thylakoid extract or composition is also provided as a food or a food supplement or as a pellet, or encapsulated granules or powder.
    Type: Application
    Filed: November 3, 2016
    Publication date: February 23, 2017
    Inventors: Marc Purcell, Rejean Drouin
  • Patent number: 9555068
    Abstract: A new use or method of use of a thylakoid extract, for oral route of administration, and a composition comprising the thylakoid extract in adjunction with an acceptable carrier for oral administration. Also described is a method for treating or preventing a disease or disorder involving the formation of reactive oxygen species inflammation in an individual, which comprises the step of orally administering an effective dose of a thylakoid extract. Also described is an oral composition comprising purified thylakoids and a carrier for oral ingestion or oral administration, with the proviso that the carrier does not essentially consist of water, physiological saline or propylene glycol. The thylakoid extract or composition is also provided as a food or a food supplement, or as a pellet, or encapsulated granules or powder.
    Type: Grant
    Filed: September 18, 2014
    Date of Patent: January 31, 2017
    Assignee: GROUPE SANTEÉ DEVONIAN
    Inventors: Marc Purcell, Réjean Drouin
  • Publication number: 20150004265
    Abstract: A new use or method of use of a thylakoid extract, for oral route of administration, and a composition comprising the thylakoid extract in adjunction with an acceptable carrier for oral administration. Also described is a method for treating or preventing a disease or disorder involving the formation of reactive oxygen species inflammation in an individual, which comprises the step of orally administering an effective dose of a thylakoid extract. Also described is an oral composition comprising purified thylakoids and a carrier for oral ingestion or oral administration, with the proviso that the carrier does not essentially consist of water, physiological saline or propylene glycol. The thylakoid extract or composition is also provided as a food or a food supplement, or as a pellet, or encapsulated granules or powder.
    Type: Application
    Filed: September 18, 2014
    Publication date: January 1, 2015
    Inventors: Marc Purcell, Réjean Drouin
  • Patent number: 8632824
    Abstract: This invention relates to a process by which an extract comprising integral thylakoids is obtained. The resulting extract is a potent dynamic antioxidant useful as a ROS (reactive oxygen species) scavenger. This extract is intended to be used for the treatment or prevention of diseases involving the generation of ROS, such as inflammatory diseases or cancer. This extract also finds a use as a solar screen because of its capacity to capture UV radiations and to dissipate the solar energy into heat.
    Type: Grant
    Filed: April 12, 2007
    Date of Patent: January 21, 2014
    Assignee: Purgenesis Technologies, Inc.
    Inventor: Marc Purcell
  • Publication number: 20130337096
    Abstract: The present document describes a buccal delivery dosage form for administration of an active ingredient, including pharmaceutically, pharmacologically, or biologically active ingredients, in the mouth of a subject. The buccal delivery dosage form by-passes the gastrointestinal tract metabolism. The buccal delivery dosage form may comprise chemical permeation enhancers, excipients, texture modulators, and active ingredients.
    Type: Application
    Filed: February 28, 2012
    Publication date: December 19, 2013
    Applicant: TECHNOLOGIES KHLOROS INC.
    Inventor: Marc Purcell
  • Publication number: 20090126747
    Abstract: The present invention relates to compositions and methods for reducing the concentration of noxious substances in gases and smoke. Filters comprising plant extracts, such as parenchyma tissue extract and mesophyll cell extract, are also provided, as well as methods for making same.
    Type: Application
    Filed: March 27, 2007
    Publication date: May 21, 2009
    Inventors: Andre L'Heureux, Stephane Dupuis, Marc Purcell
  • Publication number: 20080274217
    Abstract: The present invention provides a new use for a thylakoid extract, that is for oral route of administration, and a composition comprising the thylakoid extract in adjunction with an acceptable carrier for oral administration. Besides the pharmaceutical use, the thylakoid extract enters the composition of food or food supplements, for its inocuity and its capacity to provide a diet enriched in anti-oxidants and anti-inflammatory compounds. Therefore, in accordance with the present invention is provided the use of a thylakoid extract in the making of an oral composition for treating or preventing a disease or disorder involving the formation of reactive oxygen species or inflammation. Also is provided a method for treating or preventing a disease or disorder involving the formal of reactive oxygen species or inflammation in an individual, which comprises the step of orally administering an effective dose of a thylakoid extract.
    Type: Application
    Filed: July 11, 2008
    Publication date: November 6, 2008
    Applicant: PURECELL TECHNOLOGIES INC.
    Inventors: Marc Purcell, Rejean Drouin
  • Patent number: 7329423
    Abstract: A thylakoid extract that is preferably stabilized and activable for treating inflammation is described. Different types of cell or tissue targets and inflammatory stimuli have been used to evaluate the performance of the extract, which, in all cases successfully modulate inflammation through a balance of pro/anti-inflammatory cytokines. Compositions comprising the extract and other anti-inflammatory agents, such as glucocorticoids or non-steroidal anti-inflammatory drugs (NSAIDs) are further disclosed and claimed.
    Type: Grant
    Filed: July 2, 2002
    Date of Patent: February 12, 2008
    Assignee: Purecell Technologies Inc.
    Inventors: Alain Andersen, Elyse Bissonnette, Rejean Drouin, Marc Purcell
  • Patent number: 7270839
    Abstract: This invention relates to a process by which an extract comprising integral thylakoids is obtained. The resulting extract is a potent dynamic antioxidant useful as a ROS (reactive oxygen species) scavenger. This extract is intended to be used for the treatment or prevention of diseases involving the generation of ROS, such as inflammatory diseases or cancer. This extract also finds a use as a solar screen because of its capacity to capture UV radiations and to dissipate the solar energy into heat.
    Type: Grant
    Filed: December 29, 2000
    Date of Patent: September 18, 2007
    Assignee: Purecell Technologies Inc.
    Inventor: Marc Purcell
  • Publication number: 20070202198
    Abstract: This invention relates to a process by which an extract comprising integral thylakoids is obtained. The resulting extract is a potent dynamic antioxidant useful as a ROS (reactive oxygen species) scavenger. This extract is intended to be used for the treatment or prevention of diseases involving the generation of ROS, such as inflammatory diseases or cancer. This extract also finds a use as a solar screen because of its capacity to capture UV radiations and to dissipate the solar energy into heat.
    Type: Application
    Filed: April 12, 2007
    Publication date: August 30, 2007
    Inventor: Marc Purcell